Stock Events

Stock Events

abrdn Life Sciences Investors 

$22.15
94
+$0.04+0.18%Past Week

Statistics

Day High
-
Day Low
-
52W High
23.77
52W Low
15.07
Volume
-
Avg. Volume
0
Mkt Cap
673.54M
P/E Ratio
-
Dividend Yield
11.22%
Dividend
2.48

Upcoming

Dividends

11.22%Dividend Yield
Sep 26
$0.62
Jun 26
$0.56
Mar 26
$0.56
Jan 26
$0.50
Sep 25
$0.42
10Y Growth
-2.84%
5Y Growth
4.33%
3Y Growth
17.11%
1Y Growth
7.94%

Earnings

3JunExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q3 2022
Q1 2024
-3.03
-1.58
-0.13
1.32
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,887.77%Profit Margin
Unprofitable
2017
2018
2019
2.44MRevenue
-70.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XHQLX. It's not an investment recommendation.
AGNC Investment
23
AGNC
PIMCO Dynamic Income Fund
22
PDI
Ares Capital
20
ARCC
Cornerstone Strategic Investment Fund
19
CLM

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
VanEck Biotech
BBH
Mkt Cap0
VanEck Biotech ETF focuses on biotechnology, a core area for HQL, making it a direct competitor in the life sciences investment space.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF invests in biotechnology and pharmaceuticals, directly competing with HQL's life sciences and biotech investment focus.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF has a broad biotech focus, directly competing with HQL's investment strategy in the life sciences sector.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund is focused on biotechnology, competing with HQL's life sciences and biotech investments.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF competes by investing in biotech, a key area of focus for HQL.
Virtus Biotech
BBP
Mkt Cap0
Virtus LifeSci Biotech Products ETF focuses on biotech product companies, competing with HQL's life sciences investment strategy.
Principal Healthcare Innovators Index
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF invests in healthcare innovation, including biotech, competing with HQL's focus.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF focuses on genomics, a niche within HQL's broader life sciences investment scope, making it a competitor.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF invests in medical breakthroughs, often in biotech, competing with HQL's investment focus.

About

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
Show more...
CEO
Daniel R. Omstead
Country
United States
ISIN
US87911K1007

Listings

NASDAQ
US
XHQLX
XNYS
US
HQL

0 Comments

Share your thoughts

FAQ

What is abrdn Life Sciences Investors stock price today?▼
The current price of XHQLX is $22.15 USD — it has increased by +0.18% in the past 24 hours. Watch abrdn Life Sciences Investors stock price performance more closely on the chart.
What is abrdn Life Sciences Investors stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange abrdn Life Sciences Investors stocks are traded under the ticker XHQLX.
Is abrdn Life Sciences Investors stock price growing?▼
XHQLX stock has risen by +0.14% compared to the previous week, the month change is a +0.14% rise, over the last year abrdn Life Sciences Investors has showed a +43.37% increase.
What is abrdn Life Sciences Investors market cap?▼
Today abrdn Life Sciences Investors has the market capitalization of 673.54M
What is abrdn Life Sciences Investors revenue for the last year?▼
abrdn Life Sciences Investors revenue for the last year amounts to 2.44M USD.
What is abrdn Life Sciences Investors net income for the last year?▼
XHQLX net income for the last year is -70.48M USD.
Does abrdn Life Sciences Investors pay dividends?▼
Yes, XHQLX dividends are paid quarterly. The last dividend per share was 0.56 USD. As of today, Dividend Yield (FWD)% is 11.22%.
In which sector is abrdn Life Sciences Investors located?▼
abrdn Life Sciences Investors operates in the Finance & Payments sector.
When did abrdn Life Sciences Investors complete a stock split?▼
abrdn Life Sciences Investors has not had any recent stock splits.
Where is abrdn Life Sciences Investors headquartered?▼
abrdn Life Sciences Investors is headquartered in Philadelphia, United States.